Victory Capital Management Inc. Has $4.15 Million Stake in AmerisourceBergen Corp. (ABC)

Victory Capital Management Inc. grew its stake in shares of AmerisourceBergen Corp. (NYSE:ABC) by 4.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 45,145 shares of the company’s stock after purchasing an additional 1,858 shares during the period. Victory Capital Management Inc.’s holdings in AmerisourceBergen were worth $4,145,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of the stock. JPMorgan Chase & Co. raised its position in AmerisourceBergen by 107.3% during the third quarter. JPMorgan Chase & Co. now owns 5,363,429 shares of the company’s stock valued at $434,385,000 after buying an additional 2,776,287 shares during the period. Wells Fargo & Company MN raised its position in AmerisourceBergen by 11.4% during the third quarter. Wells Fargo & Company MN now owns 3,726,377 shares of the company’s stock valued at $308,358,000 after buying an additional 381,936 shares during the period. Harding Loevner LP raised its position in AmerisourceBergen by 89.6% during the third quarter. Harding Loevner LP now owns 3,166,794 shares of the company’s stock valued at $134,939,000 after buying an additional 1,496,761 shares during the period. Burgundy Asset Management Ltd. raised its position in AmerisourceBergen by 1.9% during the third quarter. Burgundy Asset Management Ltd. now owns 2,698,948 shares of the company’s stock valued at $223,338,000 after buying an additional 49,825 shares during the period. Finally, Beutel Goodman & Co Ltd. raised its position in AmerisourceBergen by 23.3% during the fourth quarter. Beutel Goodman & Co Ltd. now owns 2,374,727 shares of the company’s stock valued at $174,194,000 after buying an additional 449,330 shares during the period. 66.84% of the stock is currently owned by hedge funds and other institutional investors.

AmerisourceBergen Corp. (NYSE ABC) opened at $99.40 on Friday. The company has a debt-to-equity ratio of 1.61, a current ratio of 0.95 and a quick ratio of 0.50. AmerisourceBergen Corp. has a 52-week low of $71.90 and a 52-week high of $106.27. The firm has a market capitalization of $21,835.10, a PE ratio of 16.35, a price-to-earnings-growth ratio of 1.59 and a beta of 1.02.

AmerisourceBergen (NYSE:ABC) last issued its earnings results on Tuesday, February 6th. The company reported $1.55 earnings per share for the quarter, topping the consensus estimate of $1.35 by $0.20. AmerisourceBergen had a return on equity of 53.65% and a net margin of 0.66%. The company had revenue of $40.47 billion for the quarter, compared to analyst estimates of $40.42 billion. During the same period in the prior year, the firm posted $1.36 EPS. The business’s revenue was up 6.0% compared to the same quarter last year. sell-side analysts anticipate that AmerisourceBergen Corp. will post 6.58 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Monday, March 5th. Shareholders of record on Tuesday, February 20th will be given a $0.38 dividend. This represents a $1.52 annualized dividend and a yield of 1.53%. The ex-dividend date is Friday, February 16th. AmerisourceBergen’s payout ratio is currently 32.76%.

ABC has been the topic of several recent analyst reports. TheStreet raised AmerisourceBergen from a “c” rating to a “b” rating in a research report on Tuesday, February 6th. Needham & Company LLC set a $93.00 price target on AmerisourceBergen and gave the company a “buy” rating in a research report on Tuesday, October 24th. Zacks Investment Research raised AmerisourceBergen from a “hold” rating to a “buy” rating and set a $105.00 price target on the stock in a research report on Wednesday, January 3rd. Leerink Swann set a $105.00 price target on AmerisourceBergen and gave the company a “buy” rating in a research report on Tuesday, January 2nd. Finally, Goldman Sachs Group raised AmerisourceBergen from a “neutral” rating to a “buy” rating in a research report on Friday, December 15th. One analyst has rated the stock with a sell rating, six have given a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $101.17.

In other AmerisourceBergen news, CFO Tim G. Guttman sold 11,600 shares of the company’s stock in a transaction dated Monday, December 4th. The stock was sold at an average price of $85.73, for a total value of $994,468.00. Following the transaction, the chief financial officer now directly owns 56,436 shares of the company’s stock, valued at approximately $4,838,258.28. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Dale Danilewitz sold 4,459 shares of the stock in a transaction dated Monday, November 20th. The shares were sold at an average price of $78.30, for a total value of $349,139.70. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 205,355 shares of company stock worth $18,519,104. Insiders own 27.30% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This news story was originally published by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The correct version of this news story can be viewed at https://stocknewstimes.com/2018/02/18/victory-capital-management-inc-has-4-15-million-stake-in-amerisourcebergen-corp-abc.html.

About AmerisourceBergen

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.

Want to see what other hedge funds are holding ABC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AmerisourceBergen Corp. (NYSE:ABC).

Institutional Ownership by Quarter for AmerisourceBergen (NYSE:ABC)

Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply